Weiguo Cui

Dr. Weiguo Cui

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Immunity
Verified
Journal Article
Closed access
RZRyan Zander
Ryan Zander
DSDavid Schauder
David Schauder
GXGang Xin
Gang Xin
CNChristine Nguyen
Christine Nguyen
XWXiaopeng Wu
Xiaopeng Wu
WCWeiguo Cui
Weiguo Cui

19 April 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
Yiliang ChenYiliang Chen
Yiliang Chen
JZJue Zhang
Jue Zhang
WCWeiguo Cui
Weiguo Cui
RSRoy L Silverstein
Roy L Silverstein
CD36 is a type 2 cell surface scavenger receptor widely expressed in many immune and non-immune cells. It functions as both a signaling receptor responding to DAMPs and PAMPs, as well as a long chain free fatty acid transporter. Recent studies have indicated that CD36 can integrate cell signaling and metabolic pathways through its dual functions and thereby influence immune cell differentiation and activation, and ultimately help determine cell fate. Its expression along with its dual functions in both innate and adaptive immune cells contribute to pathogenesis of common diseases, including atherosclerosis and tumor progression, which makes CD36 and its downstream effectors potential therapeutic targets. This review comprehensively examines the dual functions of CD36 in a variety of immune cells, especially macrophages and T cells. We also briefly discuss CD36 function in non-immune cells, such as adipocytes and platelets, which impact the immune system via intercellular communication. Finally, outstanding questions in this field are provided for potential directions of future studies.

19 July 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YCYao Chen
Yao Chen
RZRyan A. Zander
Ryan A. Zander
XWXiaopeng Wu
Xiaopeng Wu
DSDavid M. Schauder
David M. Schauder
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
WCWeiguo Cui
Weiguo Cui

24 February 2022 in Immunity
Verified
Journal Article
Closed access
RZRyan Zander
Ryan Zander
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
YCYao Chen
Yao Chen
PTPaytsar Topchyan
Paytsar Topchyan
JSJian Shen
Jian Shen
WCWeiguo Cui
Weiguo Cui

7 December 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YCYao Chen
Yao Chen
RZRyan Zander
Ryan Zander
AKAchia Khatun
Achia Khatun
DSDavid M. Schauder
David M. Schauder
WCWeiguo Cui
Weiguo Cui
Immune protection and lasting memory are accomplished through the generation of phenotypically and functionally distinct CD8 T cell subsets. Understanding how these effector and memory T cells are formed is the first step in eventually manipulating the immune system for therapeutic benefit. In this review, we will summarize the current understanding of CD8 T cell differentiation upon acute infection, with a focus on the transcriptional and epigenetic regulation of cell fate decision and memory formation. Moreover, we will highlight the importance of high throughput sequencing approaches and single cell technologies in providing insight into genome-wide investigations and the heterogeneity of individual CD8 T cells.

1 November 2015 in Cell Reports
Verified
Journal Article
Open access
GXGang Xin
Gang Xin
DSDavid M. Schauder
David M. Schauder
BLBegoña Lainez
Begoña Lainez
JWJason S. Weinstein
Jason S. Weinstein
ZDZhengxi Dai
Zhengxi Dai
WCWeiguo Cui
Weiguo Cui
Control of chronic viral infections by CD8 T cells is critically dependent on CD4 help. In particular, helper-derived IL-21 plays a key role in sustaining the CD8 T cell response; however, the molecular pathways by which IL-21 sustains CD8 T cell immunity remain unclear. We demonstrate that IL-21 causes a phenotypic switch of transcription factor expression in CD8 T cells during chronic viral infection characterized by sustained BATF expression. Importantly, BATF expression during chronic infection is both required for optimal CD8 T cell persistence and anti-viral effector function and sufficient to rescue "unhelped" CD8 T cells. Mechanistically, BATF sustains the response by cooperating with IRF4, an antigen-induced transcription factor that is also critically required for CD8 T cell maintenance, to preserve Blimp-1 expression and thereby sustain CD8 T cell effector function. Collectively, these data suggest that CD4 T cells "help" the CD8 response during chronic infection via IL-21-induced BATF expression.